U.S. Medical Imaging Systems Market to Hit $30.5B by 2035

Market Outlook

By 2035, the U.S. Medical Imaging Systems Market is expected to reach approximately USD 30.50 billion, expanding at a CAGR of 6.80% during the forecast period 2026–2035. The market was valued at an estimated USD 15.80 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions. The market scope includes diagnostic X-ray and radiography systems, computed tomography systems, magnetic resonance imaging systems, ultrasound systems, and nuclear or molecular imaging platforms, together with major system upgrades, embedded acquisition and reconstruction software, and system-linked service revenue. Standalone radiology information systems, contrast media, and radiation therapy equipment are excluded.

The U.S. medical imaging systems industry is one of the most strategically important capital-equipment markets in healthcare because imaging influences diagnosis, treatment selection, procedural guidance, surgical planning, emergency triage, cancer surveillance, and longitudinal disease management. Demand is supported by a healthcare delivery system containing approximately 6,100 hospitals, more than 907,000 staffed beds, and nearly 35.7 million annual hospital admissions. Imaging equipment is also installed across independent diagnostic centers, physician practices, ambulatory surgery centers, cancer centers, urgent-care networks, emergency departments, orthopedic clinics, cardiology practices, women’s health facilities, and mobile imaging providers.

Clinical demand is structurally durable. The U.S. population aged 65 and older reached approximately 61.2 million in 2024, increasing the number of patients requiring imaging for cancer, stroke, cardiovascular disease, dementia, pulmonary disease, musculoskeletal degeneration, and trauma. An estimated 2.04 million new cancer cases were expected in the United States in 2025, reinforcing demand for CT, MRI, PET/CT, SPECT/CT, ultrasound, and mammography across detection, staging, treatment planning, and follow-up. Breast imaging alone represents a major installed-base opportunity: more than 41.8 million mammography procedures were reported nationally in 2024, while the U.S. operated more than 12,000 accredited digital breast tomosynthesis units.

The market is moving from equipment replacement toward platform modernization. Hospitals are no longer evaluating scanners only on image quality or purchase price. Procurement committees are comparing patient throughput, scan time, staffing requirements, dose efficiency, room preparation, energy use, helium dependence, uptime, interoperability, cybersecurity, remote serviceability, and the ability to deploy AI across an enterprise fleet. Systems that shorten protocols, reduce repeat scans, standardize acquisition across technologists, and support more exams per operating hour are gaining preference because they improve both clinical performance and asset utilization.

The historical market expanded from approximately USD 12.30 billion in 2021 to USD 14.85 billion in 2024. Growth reflected recovery in deferred capital projects, increased outpatient imaging volumes, replacement of aging CT and MRI fleets, stronger demand for mobile radiography and point-of-care ultrasound, continued conversion from two-dimensional mammography to digital breast tomosynthesis, and early adoption of spectral CT, photon-counting CT, AI-assisted reconstruction, and low-helium MRI. The market reached an estimated USD 15.80 billion in 2025 as health systems prioritized productivity, diagnostic confidence, and enterprise standardization despite continued pressure on labor and capital budgets.

Introduction

According to the U.S. Medical Imaging Systems Market Report, the industry is shaped by a combination of high diagnostic intensity, sophisticated provider infrastructure, strong specialist networks, advanced reimbursement pathways, and rapid technology replacement. Medical imaging is embedded in nearly every high-value clinical service line. Oncology programs depend on imaging for screening, staging, biopsy guidance, treatment planning, response assessment, and recurrence surveillance. Emergency departments use CT, X-ray, and ultrasound to triage trauma, stroke, abdominal pain, pulmonary embolism, and acute cardiac conditions. Orthopedic and neurological pathways rely on MRI and CT for structural assessment, while cardiology increasingly uses advanced CT, echocardiography, nuclear imaging, and image-guided intervention.

The market is not a uniform capital-equipment category. It combines mature, high-volume platforms such as digital radiography and ultrasound with high-ticket CT, MRI, PET/CT, and SPECT/CT systems. It also includes mobile and handheld devices, hybrid systems, specialized women’s imaging platforms, AI-enabled reconstruction packages, workflow orchestration tools, and recurring maintenance or upgrade contracts linked to installed equipment. This diversified revenue model reduces dependence on any single procedure category and creates multiple replacement cycles across hospitals and outpatient sites.

U.S. hospital economics are central to market performance. Hospital spending reached approximately USD 1.63 trillion in 2024, but imaging departments continue to operate under cost pressure from technologist shortages, radiologist workload, service-contract inflation, construction costs, and reimbursement variability. A premium scanner must therefore provide measurable operational value. Buyers increasingly ask whether a system can reduce a 30-minute protocol to 20 minutes, avoid sedation, increase daily slots, lower dose, reduce contrast use, minimize downtime, or allow a remote expert to support multiple locations. Imaging manufacturers that can quantify these outcomes are better positioned to protect pricing and win multi-year enterprise agreements.

From 2026 to 2035, the defining strategic shift will be from standalone scanners to connected imaging ecosystems. Competitive advantage will depend on how effectively a manufacturer integrates acquisition, reconstruction, visualization, workflow automation, remote operations, fleet analytics, cybersecurity, clinical applications, and lifecycle service. Health systems will favor vendors that can support consistent protocols across flagship hospitals, community sites, ambulatory centers, and rural facilities while allowing local flexibility. The result will be a market where software capability, implementation execution, and service reliability influence hardware share as much as detector performance, field strength, or gantry design.

Key Market Drivers: What’s Fueling the U.S. Medical Imaging Systems Market Boom?

The first major driver is the scale and complexity of disease burden in the United States. Aging increases the prevalence of cancer, osteoarthritis, stroke, coronary disease, neurodegenerative conditions, and chronic pulmonary disorders, all of which require repeated imaging. The 65-and-older population already exceeds 61 million, and the number of older adults is expected to continue rising through the forecast period. This creates recurring demand not only for initial diagnosis but also for surveillance, therapy response assessment, preoperative planning, and post-treatment monitoring. Imaging utilization therefore grows with both patient volume and the number of imaging events per patient.

A second driver is the replacement and modernization of the installed base. CT and MRI systems are long-lived assets, but older platforms can become economically inefficient before they become clinically unusable. Legacy scanners may have slower reconstruction, limited cardiac capability, higher dose, narrower bores, greater helium requirements, less automation, and weaker cybersecurity support. Hospitals facing rising volumes are increasingly choosing replacement rather than extending equipment life when a new system can materially improve throughput. Large integrated delivery networks are also standardizing fleets to simplify training, service, protocol management, and software deployment across multiple facilities.

A third driver is the expansion of oncology and population-based screening. The United States expected more than 2 million new cancer diagnoses in 2025, and imaging is required across most major tumor pathways. Lung cancer screening supports low-dose CT demand. Breast cancer screening sustains mammography and tomosynthesis replacement, with more than 41 million annual mammography procedures creating one of the largest recurring screening workflows in diagnostic imaging. Colorectal screening, prostate cancer assessment, liver surveillance, and neurological imaging are also expanding the use of CT, MRI, ultrasound, and molecular imaging. The federal breast-density notification requirement that became enforceable in September 2024 is increasing attention to supplemental ultrasound and MRI pathways for selected patients with dense breast tissue.

A fourth driver is the migration of care to outpatient and distributed settings. Independent imaging centers, hospital outpatient departments, orthopedic clinics, cardiology practices, urgent-care networks, and ambulatory surgery centers are investing in equipment that fits smaller footprints and lower-cost operating models. Outpatient buyers prioritize predictable uptime, rapid patient turnover, simplified protocols, compact siting, and lower total ownership cost. This favors wide-bore MRI, compact CT, mobile C-arms, cart-based ultrasound, and handheld point-of-care platforms. It also increases demand for remote protocol support and centralized quality management because smaller sites may not have subspecialty technologists available at all times.

A fifth driver is the radiology and technologist workforce constraint. Imaging demand is growing faster than the supply of experienced personnel in many markets. U.S. radiology organizations have reported large numbers of open physician positions, while hospitals continue to face shortages of MRI, CT, mammography, and ultrasound technologists. This makes automation economically important. Auto-positioning, protocol selection, anatomy recognition, motion correction, deep-learning reconstruction, automated measurements, structured reporting, and worklist prioritization can reduce variability and allow scarce staff to manage more studies. The strongest value proposition for AI is therefore not autonomous diagnosis alone; it is the removal of repetitive operational steps across acquisition and interpretation.

A sixth driver is the rise of image-guided and precision-care workflows. CT, MRI, ultrasound, and nuclear imaging are increasingly used to guide biopsies, ablation, structural heart procedures, vascular interventions, orthopedic surgery, neurosurgery, radiation planning, and theranostic treatment. This shifts imaging from a diagnostic department into a procedural infrastructure layer. Hybrid operating rooms, interventional suites, and oncology centers require high-resolution imaging, navigation compatibility, fusion capability, and real-time visualization. Systems that can support both diagnostic and procedural use improve asset productivity and strengthen the business case for capital investment.

A seventh driver is reimbursement and regulatory support for selected high-value imaging pathways. Medicare coverage decisions, preventive screening policies, accreditation requirements, and quality standards influence equipment demand. CMS coverage of screening CT colonography, continued reimbursement for advanced imaging, and federal mammography quality requirements support utilization, while appropriate-use frameworks push providers toward clinically justified exams. At the same time, reimbursement pressure encourages health systems to reduce repeat imaging, avoid unnecessary contrast, and move suitable exams to lower-cost settings. Manufacturers must therefore align technology claims with coding, coverage, and site-of-service economics.

An eighth driver is the growing importance of energy, infrastructure, and resilience. MRI siting has historically required substantial helium, electrical, cooling, and construction resources. Newer low-helium and helium-sealed systems reduce installation risk and lifecycle exposure. CT and MRI vendors are also introducing standby modes, more efficient components, remote monitoring, and predictive maintenance. These features matter as health systems pursue sustainability targets and attempt to reduce unplanned downtime. A scanner that is clinically advanced but difficult to install or service may lose to a platform with slightly lower specifications but superior lifecycle economics.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. medical imaging systems market is increasingly centered on diagnostic precision, workflow automation, lower resource intensity, and enterprise scalability. The competitive objective is no longer simply to produce a sharper image. Manufacturers are building systems that acquire data faster, reconstruct images with less noise, reduce radiation or contrast burden, identify quality problems during the exam, guide technologists through complex protocols, and distribute specialist expertise across multiple sites.

Photon-counting and spectral CT are among the most important innovation areas. Conventional CT detectors integrate X-ray energy, while photon-counting detectors can measure individual photons and separate energy levels. This can improve spatial resolution, material characterization, and dose efficiency. Spectral CT also provides information beyond conventional attenuation by differentiating materials and generating virtual non-contrast or iodine maps. These capabilities are especially relevant in cardiovascular, oncology, pulmonary, neurological, and musculoskeletal imaging. Adoption will initially concentrate in academic and high-volume referral centers, but broader penetration is expected as workflow, reimbursement, and economic evidence mature.

AI-enabled reconstruction is changing the economics of CT and MRI. Deep-learning methods can reduce noise, accelerate acquisition, sharpen anatomy, and support lower-dose or shorter protocols. In MRI, faster scanning can increase daily capacity, reduce motion, lower the need for sedation, and improve patient tolerance. In CT, better reconstruction can support dose reduction while maintaining diagnostic confidence. The commercial advantage is strongest when AI is embedded directly into acquisition and reconstruction rather than sold as a disconnected application, because embedded tools influence every exam and can be evaluated through measurable throughput gains.

MRI innovation is also addressing helium dependence, footprint, access, and patient experience. New closed-circuit and low-helium magnets require dramatically less liquid helium than conventional systems, reducing installation complexity and exposure to helium supply volatility. Wide-bore designs improve accessibility for larger, anxious, or mobility-limited patients. Low-field and portable MRI systems are expanding the addressable market in intensive care, emergency, neurological, and resource-constrained settings. Although portable MRI will not replace high-field systems for complex imaging, it can create a new workflow where critically ill patients are scanned closer to the bedside rather than transported through the hospital.

Ultrasound is advancing through miniaturization, software-defined probes, automated measurements, and AI guidance. Handheld ultrasound is moving beyond basic visualization toward guided image acquisition, automated ejection-fraction estimation, bladder volume, obstetric measurement, vascular access, and pulmonary assessment. The market opportunity is large because ultrasound can be deployed in emergency medicine, anesthesia, critical care, primary care, cardiology, obstetrics, and home-based services. However, commercial success depends on training, governance, image quality, connectivity, and the ability to integrate findings into the medical record.

Molecular imaging is evolving through digital detectors, long-axial-field-of-view PET, higher sensitivity, faster acquisition, lower administered dose, and theranostic workflows. Growth in prostate-specific membrane antigen imaging, amyloid imaging, and targeted radiopharmaceutical therapies is increasing demand for PET/CT, SPECT/CT, dosimetry, and quantitative software. Health systems developing theranostics programs need not only scanners but also radiopharmacy coordination, treatment planning, radiation safety, patient scheduling, and longitudinal quantification. Vendors able to combine hardware, analytics, and oncology workflow support can capture a larger share of this emerging value pool.

Remote imaging operations represent another important innovation cycle. FDA-cleared remote scanning and protocol-management capabilities allow experienced technologists or specialists to support multiple sites from a central command center. This model can help community hospitals and outpatient centers maintain protocol consistency, cover staffing gaps, and extend advanced imaging hours. It also supports hub-and-spoke health systems in which complex expertise is concentrated at a flagship site. Remote operations will become increasingly important as providers standardize imaging fleets across geographically dispersed networks.

Manufacturers are also raising the bar through lifecycle services and evidence. Predictive maintenance, fleet analytics, cybersecurity updates, remote diagnostics, uptime guarantees, and subscription-based software upgrades are becoming part of the purchasing decision. U.S. buyers increasingly expect proof that a new system can deliver faster exams, fewer repeats, lower dose, reduced room downtime, improved diagnostic confidence, or better patient access. Vendors that can translate technical performance into measurable service-line economics will gain an advantage over those relying on specification-based selling.

Segmentation Insights

The U.S. Medical Imaging Systems Market is segmented on the basis of modality, application, system configuration, end user, and region.

By Modality

X-ray and Radiography Systems

X-ray and radiography systems represented the largest modality segment in 2025, with an estimated market value of approximately USD 4.30 billion. The segment includes fixed digital radiography, mobile radiography, fluoroscopy, C-arms, mammography, digital breast tomosynthesis, and specialized radiographic platforms. Its leadership is supported by high exam volume, broad clinical use, shorter replacement cycles than some high-end modalities, and extensive deployment across hospitals, emergency departments, orthopedic practices, urgent-care centers, surgical suites, and women’s imaging facilities.

Digital breast tomosynthesis is an important premium subsegment. The U.S. had more than 12,000 accredited DBT units and over 41.8 million annual mammography procedures reported in 2024, supporting recurring upgrades in detector technology, AI-assisted reading, workflow software, and biopsy guidance. Mobile radiography is also gaining importance because it supports bedside imaging in intensive care, emergency, postoperative, and infection-control workflows. Over the forecast period, X-ray growth will be driven less by basic conversion from analog to digital and more by detector upgrades, automated positioning, dose management, mobile workflow, surgical imaging, and enterprise standardization.

Computed Tomography Systems

Computed tomography accounted for an estimated USD 3.55 billion in 2025 and is expected to be one of the fastest-growing major modalities. The segment includes conventional multi-slice CT, high-slice cardiac CT, spectral CT, photon-counting CT, portable CT, and specialized intraoperative systems. CT is central to emergency care, oncology, cardiovascular imaging, lung screening, trauma, stroke, and image-guided intervention, making it one of the most highly utilized assets in acute-care hospitals.

Growth is shifting toward premium systems that deliver faster rotation, improved cardiac performance, lower dose, better material differentiation, and automated workflow. Photon-counting CT will initially represent a small share of installed units but a disproportionate share of value growth because of high selling prices and strong interest from academic and tertiary centers. Spectral capability is also moving from a specialized feature toward a broader clinical platform. Manufacturers that can demonstrate diagnostic value without adding workflow complexity will be best positioned as these technologies move into community settings.

Magnetic Resonance Imaging Systems

MRI generated an estimated USD 3.20 billion in 2025. The segment includes 1.5T, 3T, low-field, open, ultra-high-field, portable, and specialty MRI systems. The 1.5T category remains the installed-base standard because it supports broad clinical use and predictable operating economics. The 3T segment commands premium demand in neurological, musculoskeletal, cardiovascular, prostate, breast, and research imaging. Low-field and portable systems are expanding access in settings where conventional MRI is difficult to site or where bedside imaging can change workflow.

MRI growth is being accelerated by AI reconstruction, compressed sensing, motion correction, wider bores, lower helium requirements, and faster protocols. Throughput is the critical economic variable. A system that reduces scan time while maintaining quality can add appointments without requiring a second magnet, which can materially improve return on capital. The market will therefore reward platforms that combine hardware performance with protocol automation, patient comfort, and lifecycle efficiency.

Ultrasound Systems

Ultrasound represented approximately USD 2.95 billion in 2025 and spans premium cart-based systems, compact systems, handheld devices, point-of-care ultrasound, and application-specific platforms for cardiology, obstetrics, vascular imaging, anesthesia, emergency medicine, and general imaging. The segment benefits from the absence of ionizing radiation, relatively low acquisition cost, broad clinical versatility, and portability.

Handheld and point-of-care ultrasound are the fastest-growing subsegments because they expand imaging beyond the radiology department. Adoption is increasing in emergency departments, intensive care units, operating rooms, primary-care settings, ambulances, and home-based services. Premium growth will come from AI-guided acquisition, automated quantification, transducer innovation, wireless connectivity, and enterprise governance tools. Cart-based systems will remain essential for complex echocardiography, obstetric, vascular, and abdominal exams where advanced image quality and specialized probes are required.

Nuclear and Molecular Imaging Systems

Nuclear and molecular imaging systems accounted for an estimated USD 1.80 billion in 2025. The segment includes PET/CT, SPECT/CT, PET/MRI, dedicated cardiac systems, and specialized organ imaging platforms. It is the smallest major modality by installed-unit volume but one of the highest-value and fastest-growing categories because of oncology, neurology, cardiology, and theranostics.

Growth is being supported by PSMA imaging and therapy pathways, amyloid and neurodegenerative disease imaging, digital detector adoption, quantitative imaging, and faster whole-body acquisition. Long-axial-field-of-view PET can increase sensitivity and reduce scan time, but adoption will depend on capital availability, radiotracer access, patient volume, and reimbursement. Health systems building comprehensive cancer centers are likely to prioritize molecular imaging because it strengthens precision oncology, clinical trials, and targeted radiopharmaceutical services.

By Application

Oncology

Oncology is the largest application segment and represented an estimated 28% of the U.S. market in 2025. Cancer pathways use mammography, CT, MRI, ultrasound, PET/CT, SPECT/CT, and image-guided systems from screening through survivorship. The expected 2.04 million new U.S. cancer cases in 2025 create substantial demand for staging, radiation planning, biopsy guidance, treatment response, and recurrence monitoring. Oncology buyers place high value on reproducibility, quantitative comparison, multimodality registration, and integration with pathology, radiation oncology, and molecular diagnostics.

Cardiology and Vascular Imaging

Cardiology and vascular imaging form a high-value application segment encompassing cardiac CT, echocardiography, cardiac MRI, nuclear cardiology, fluoroscopy, and image-guided intervention. Demand is supported by coronary artery disease, structural heart disease, heart failure, arrhythmia, and peripheral vascular disease. Growth will be strongest in coronary CT angiography, spectral and photon-counting CT, advanced echocardiography, plaque characterization, and procedural fusion imaging. Systems that support noninvasive diagnosis and minimally invasive intervention can influence both diagnostic and therapeutic service-line economics.

Neurology

Neurology applications include stroke, brain tumor, epilepsy, dementia, multiple sclerosis, traumatic brain injury, and spine disease. CT remains essential for emergency stroke and trauma, while MRI provides detailed neurological and soft-tissue assessment. PET is becoming more relevant for selected neurodegenerative disease pathways. Growth is supported by aging demographics, rising dementia burden, stroke network expansion, and the need for faster emergency imaging. Portable CT and MRI can add value in intensive-care and neurological settings by reducing patient transport.

Orthopedic and Musculoskeletal Imaging

Orthopedic and musculoskeletal imaging is supported by sports injury, osteoarthritis, spine disorders, trauma, and an aging population. MRI, X-ray, CT, ultrasound, and weight-bearing imaging systems are used across hospitals, orthopedic practices, sports medicine centers, and ambulatory surgery facilities. Demand is shifting toward faster MRI protocols, extremity imaging, low-dose CT, weight-bearing CT, and compact systems that can be placed closer to orthopedic clinics. Outpatient economics are particularly important because many musculoskeletal exams are price-sensitive and scheduled outside hospital campuses.

Women’s Health, Pulmonary, Abdominal, and General Imaging

This combined application segment includes breast imaging, obstetrics and gynecology, lung screening, abdominal imaging, emergency diagnostics, and general radiology. Mammography and DBT dominate women’s imaging, while supplemental ultrasound and MRI are gaining attention for selected high-risk or dense-breast patients. Pulmonary imaging is driven by lung cancer screening, chronic lung disease, infection, and emergency evaluation. General imaging remains a broad and stable demand base across hospitals and outpatient centers, ensuring recurring replacement for radiography, ultrasound, CT, and MRI systems.

By System Configuration

Fixed Room-Based Systems

Fixed room-based systems accounted for approximately 74% of market revenue in 2025. This category includes conventional CT, MRI, PET/CT, SPECT/CT, fixed radiography, fluoroscopy, mammography, and premium cart-based ultrasound installed in dedicated rooms. Fixed systems command the largest share because high-field magnets, advanced CT gantries, and molecular imaging platforms require specialized infrastructure and support high exam volumes. Future purchasing will focus on compact footprints, faster installation, energy efficiency, workflow automation, and room designs that improve patient movement and staff safety.

Mobile and Cart-Based Systems

Mobile and cart-based systems include mobile radiography, mobile C-arms, compact ultrasound, mobile CT, and relocatable imaging units. This segment is supported by bedside care, operating-room imaging, critical care, rural outreach, and temporary capacity requirements. Hospitals value mobile systems that reduce patient transport and improve access in high-acuity areas. The strongest growth opportunities are in battery performance, wireless detector integration, navigation compatibility, and fleet management.

Portable and Handheld Systems

Portable and handheld systems are the fastest-growing configuration segment. Handheld ultrasound, portable X-ray, and bedside low-field MRI are expanding imaging into settings that historically relied on physical examination or patient transfer. These systems can improve time to diagnosis in emergency, intensive-care, primary-care, military, and home-based workflows. Adoption will depend on training, image quality, clinical governance, reimbursement, and connectivity. Vendors that provide education, credentialing support, and secure data integration will be better positioned than those selling hardware alone.

Hybrid and Specialty Systems

Hybrid and specialty systems include PET/CT, SPECT/CT, PET/MRI, intraoperative imaging, cone-beam CT, weight-bearing CT, dedicated breast CT, and specialized cardiac or neurological platforms. These systems address complex workflows where conventional general-purpose imaging may be less efficient. Although the installed base is smaller, average selling prices and clinical differentiation are high. Growth will be concentrated in tertiary centers, cancer programs, orthopedic networks, and image-guided procedural environments.

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks accounted for an estimated 58% of 2025 market revenue. They purchase the broadest range of systems and dominate high-acuity CT, MRI, molecular imaging, fluoroscopy, mobile radiography, interventional imaging, and advanced ultrasound. Large systems increasingly use enterprise contracts to standardize vendors across multiple hospitals and outpatient sites. Procurement decisions involve radiology leadership, finance, facilities, IT, cybersecurity, clinical engineering, supply chain, and value-analysis committees. Winning these accounts requires strong service coverage, implementation discipline, and fleet-level economics.

Independent Diagnostic Imaging Centers

Independent imaging centers represented approximately 22% of market revenue and are especially important for MRI, CT, mammography, ultrasound, and radiography. These buyers operate under high utilization and price sensitivity, making throughput and uptime critical. They may select refurbished or mid-range systems when premium features do not create reimbursable value, but they will invest in advanced platforms when faster exams, broader indications, or patient experience can support referral growth. Compact siting and predictable service costs are major purchase criteria.

Specialty Clinics and Ambulatory Surgery Centers

Orthopedic practices, cardiology groups, women’s health centers, oncology clinics, urology practices, and ambulatory surgery centers are growing imaging buyers. Their demand is concentrated in ultrasound, mobile C-arms, radiography, extremity MRI, compact CT, and application-specific systems. These providers seek equipment aligned with a defined procedure mix rather than broad enterprise capability. Vendors that offer tailored financing, low-footprint installation, and specialty workflow packages can gain share in this segment.

Emergency, Urgent-Care, Rural, and Mobile Providers

Emergency departments, urgent-care chains, rural hospitals, critical-access hospitals, and mobile imaging providers require reliable systems that can operate with limited staff and infrastructure. Mobile radiography, compact CT, ultrasound, and remote operations are especially relevant. Rural markets may not support a full-time subspecialty workforce, increasing the value of automated protocols, remote scanning support, and cloud-based interpretation. This segment is strategically important because access expansion can create new equipment demand outside major metropolitan centers.

Academic Medical Centers and Research Institutions

Academic centers represent a smaller revenue share but have disproportionate influence on innovation adoption. They are early buyers of photon-counting CT, 7T MRI, long-axial-field-of-view PET, advanced neuroimaging, research ultrasound, and AI platforms. These institutions generate evidence, train specialists, and influence clinical guidelines. Manufacturers use academic partnerships to validate new applications and develop reference sites, but sales cycles can be complex because of grant funding, research requirements, and multi-department governance.

Regional Insights: Where the Market is Growing Fastest

The U.S. Medical Imaging Systems Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age distribution, hospital density, specialty-center concentration, capital availability, outpatient imaging penetration, chronic disease burden, rural access, and adoption of advanced technology. The South represented the largest regional market in 2025, while the West is expected to record the fastest CAGR through 2035. The Northeast remains the highest-acuity and research-intensive market, and the Midwest provides a stable base of hospital and community imaging demand.

South

The South was the largest regional market, valued at approximately USD 5.25 billion in 2025, and is projected to approach USD 10.2 billion by 2035. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, the District of Columbia, Tennessee, Kentucky, Alabama, Mississippi, Arkansas, Louisiana, and Oklahoma. Its leadership is supported by population scale, rapid migration into major metropolitan areas, a large older-adult population, high chronic disease burden, and continued health-system construction.

Texas is the most important state market in the region. Houston, Dallas–Fort Worth, Austin, and San Antonio support large academic centers, trauma networks, cancer programs, and integrated delivery systems. Demand is broad across CT, MRI, molecular imaging, women’s imaging, surgical C-arms, and ultrasound. Texas also has extensive rural geography, creating parallel demand for mobile imaging, compact systems, and remote operations. Health systems expanding into suburban markets are increasingly standardizing equipment across flagship and satellite facilities.

Florida is another major imaging market because of its large and rapidly growing older population. Demand is particularly strong for oncology imaging, cardiac CT, MRI, PET/CT, mammography, musculoskeletal imaging, and outpatient diagnostics. Large senior populations support recurring surveillance and chronic-disease imaging, while hospital consolidation creates opportunities for enterprise fleet contracts. The state’s outpatient market is highly competitive, making throughput, patient experience, and referral turnaround essential purchase criteria.

North Carolina, Georgia, Virginia, Maryland, and Tennessee are attractive growth markets. North Carolina combines academic research centers with expanding suburban health systems. Georgia benefits from Atlanta’s regional referral network and population growth. Virginia and Maryland have sophisticated provider systems, federal healthcare activity, and strong oncology and neurological programs. Tennessee has important hospital operators and regional medical hubs in Nashville, Memphis, and Knoxville. South Carolina is smaller but benefits from coastal population growth and expanding hospital capacity.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma have substantial need for imaging related to cardiovascular disease, cancer, diabetes complications, trauma, and rural access. Capital budgets can be more constrained outside major cities, increasing demand for mid-range, refurbished, mobile, and service-efficient systems. Regional referral centers in Birmingham, New Orleans, Lexington, Louisville, Charleston, Little Rock, Oklahoma City, and Tulsa remain important buyers of advanced CT, MRI, and molecular imaging. Delaware and the District of Columbia are smaller markets but have high provider density and strong access to tertiary care.

The South will remain the largest region through 2035 because it combines large state markets with population growth and ongoing hospital expansion. The strongest opportunities will be in replacement CT and MRI, outpatient imaging, women’s health, mobile radiography, point-of-care ultrasound, and enterprise fleet modernization. Vendors must address both premium metropolitan demand and cost-sensitive rural access requirements.

West

The West represented an estimated USD 3.95 billion in 2025 and is expected to reach approximately USD 8.14 billion by 2035, reflecting an above-market CAGR of about 7.5%. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii. Growth is supported by technology adoption, population expansion in several states, outpatient care models, major academic centers, and a strong digital-health ecosystem.

California is the largest state market in the West and one of the most influential imaging markets nationally. It combines large academic systems, comprehensive cancer centers, dense outpatient imaging networks, and a strong medtech and AI ecosystem. California is an early-adoption market for photon-counting CT, advanced MRI, PET imaging, remote operations, imaging AI, and cloud-based informatics. However, labor costs, construction expenses, and regulatory complexity place strong emphasis on systems that reduce staffing needs and improve utilization.

Washington and Oregon have sophisticated integrated delivery networks and strong adoption of connected care. Provider systems in Seattle, Portland, and surrounding markets frequently evaluate fleet analytics, remote reading, standardized protocols, and lower-energy equipment. Washington also has major cancer and research programs that support advanced molecular imaging and MRI. Oregon’s more distributed population creates demand for regional imaging networks and remote support.

Arizona, Nevada, Colorado, and Utah are among the region’s fastest-growing state markets. Arizona and Nevada benefit from migration, aging populations, and hospital construction in Phoenix, Tucson, Las Vegas, and Reno. Colorado has advanced academic and community systems in the Denver corridor, while Utah combines integrated care delivery with strong technology adoption. These states are attractive for outpatient CT, MRI, mammography, ultrasound, and orthopedic imaging because population growth is creating new suburban access points.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller but strategically important access markets. Long travel distances, rural communities, and uneven specialist availability increase the value of mobile systems, compact imaging, tele-radiology, and remote technologist support. Alaska and Hawaii face additional logistics and service challenges, making uptime, parts availability, and remote diagnostics critical. Idaho and Montana are benefiting from population growth, while New Mexico continues to require scalable solutions for rural and tribal communities.

The West will gain share as imaging becomes more software-defined, decentralized, and connected. Manufacturers with strong AI integration, remote operations, cybersecurity, and compact system design will be well positioned. The region will also remain important for clinical validation and partnerships between health systems, universities, and technology companies.

Northeast

The Northeast accounted for an estimated USD 3.75 billion in 2025 and is projected to reach approximately USD 6.97 billion by 2035. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, and Maine. It has slower population growth than the South and West but remains one of the highest-value markets because of academic medical centers, specialist density, complex case mix, research funding, and advanced hospital infrastructure.

New York is the largest state market in the Northeast. New York City and major upstate systems support high volumes in oncology, emergency care, cardiac imaging, neuroimaging, and women’s health. Space constraints in urban hospitals increase demand for compact systems, efficient room design, and high throughput. Large health systems also use enterprise agreements to manage equipment across academic hospitals, community facilities, and outpatient centers.

Pennsylvania and New Jersey provide large, diverse imaging markets. Pennsylvania combines major academic centers in Philadelphia and Pittsburgh with extensive community and rural networks. New Jersey has high population density, strong outpatient imaging penetration, and proximity to major research and pharmaceutical ecosystems. Both states are important for MRI, CT, mammography, PET/CT, and interventional imaging.

Massachusetts is highly influential because of its concentration of teaching hospitals, research institutions, and biotechnology activity. It is an early market for advanced MRI, molecular imaging, AI, and quantitative imaging. Connecticut and Rhode Island have mature provider networks and strong access to tertiary care, while New Hampshire, Vermont, and Maine have older populations and more rural geography. These northern states create demand for efficient regional networks, mobile services, and remote operational support.

Procurement in the Northeast is highly evidence-driven. Buyers often require clinical validation, cybersecurity review, interoperability testing, and detailed health-economic justification. Growth will be steady rather than volume-led, with value concentrated in premium replacement, AI upgrades, oncology imaging, advanced neuroimaging, and fleet modernization.

Midwest

The Midwest represented approximately USD 2.85 billion in 2025 and is expected to reach about USD 5.20 billion by 2035. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota. Demand is supported by established hospital networks, large community health systems, major academic centers, chronic disease burden, and a strong medical-device manufacturing heritage.

Illinois, Ohio, Michigan, and Minnesota are the largest state markets. Chicago supports a dense mix of academic, community, and outpatient providers. Ohio has major health systems and high imaging capacity across Cleveland, Columbus, and Cincinnati. Michigan has significant demand in Detroit, Grand Rapids, and regional systems, particularly for cardiac, oncology, and musculoskeletal imaging. Minnesota is strategically important because of its medtech ecosystem, integrated delivery networks, and advanced specialty care.

Wisconsin, Indiana, and Missouri provide stable replacement demand across hospitals and outpatient centers. Milwaukee, Madison, Indianapolis, St. Louis, and Kansas City are important imaging hubs. These states are attractive for enterprise standardization because large health systems often operate multiple community facilities across broad geographies. Iowa and Kansas have smaller populations but strong regional providers and growing demand for remote support, mobile imaging, and service-efficient systems.

Nebraska, North Dakota, and South Dakota are smaller markets with large rural service areas. Imaging access depends on regional referral centers, critical-access hospitals, mobile providers, and tele-radiology. Compact CT, mobile radiography, ultrasound, and remote scanning can create meaningful value by reducing patient transfers. The Midwest is likely to grow more slowly than the West and South, but it remains a durable market where service reliability, cost control, and long-term customer relationships are especially important.

Key Market Players

The U.S. Medical Imaging Systems Competitive Landscape is moderately consolidated at the top. GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, and Fujifilm Healthcare control substantial shares across CT, MRI, ultrasound, X-ray, molecular imaging, and enterprise informatics. Hologic is highly influential in women’s imaging, while Samsung, Carestream, Konica Minolta, Shimadzu, and Agfa compete in targeted modality and workflow categories. A growing group of specialized companies is expanding the market through handheld ultrasound, portable MRI, dedicated CT, specialty breast imaging, and software-defined platforms.

Competition is increasingly platform-based. Large manufacturers use broad portfolios, installed-base service, financing, clinical applications, and enterprise contracting to defend share. Specialized companies can win when they address a specific workflow that incumbents do not solve efficiently, such as bedside MRI, handheld ultrasound, weight-bearing CT, dedicated breast CT, or organ-specific molecular imaging. Over the forecast period, competitive position will depend on FDA clearance velocity, evidence generation, supply-chain reliability, cybersecurity, service responsiveness, AI integration, and the ability to prove economic value at the health-system level.

Some of the key players in the U.S. Medical Imaging Systems industry are:

GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems USA
Fujifilm Healthcare Americas
United Imaging Healthcare
Hologic
Samsung Healthcare and NeuroLogica
Carestream Health
Konica Minolta Healthcare Americas
Shimadzu Medical Systems USA
Agfa HealthCare
Esaote North America
Mindray North America
Butterfly Network
Hyperfine
Clarius Mobile Health
Exo Imaging
Sectra
Planmed USA
Ziehm Imaging
Spectrum Dynamics Medical
Koning Corporation
CurveBeam AI
Nanox

GE HealthCare and Siemens Healthineers are particularly strong in high-value CT, MRI, molecular imaging, and enterprise platforms. Philips competes through imaging, ultrasound, workflow, remote operations, and image-guided care. Canon has a strong CT, ultrasound, and MRI presence, while Fujifilm combines diagnostic imaging systems with informatics and an expanded modality portfolio. United Imaging is competing aggressively in CT, MRI, PET/CT, and radiation-related imaging through technology-rich platforms and value-based positioning.

Hologic remains a major force in mammography and breast tomosynthesis. Samsung, Mindray, Butterfly, Clarius, and Exo are important in ultrasound and point-of-care imaging. Hyperfine is building a new bedside MRI category, while CurveBeam AI, Koning, and Spectrum Dynamics address specialized orthopedic, breast, and molecular imaging applications. The success of these challengers will depend on whether they can scale service, reimbursement support, training, and clinical evidence beyond early-adopter sites.

Recent Developments

Recent developments in the U.S. Medical Imaging Systems Market show a clear shift toward AI-enabled acquisition, remote operations, lower-resource hardware, and multimodality workflow integration. In April 2024, GE HealthCare completed its acquisition of MIM Software, strengthening its imaging analytics, quantitative analysis, and workflow capabilities across oncology, molecular imaging, neurology, cardiology, and urology. The transaction illustrates how major equipment manufacturers are expanding beyond scanners into longitudinal precision-care platforms.

Remote imaging operations also moved closer to routine deployment. In November 2024, Philips received FDA 510(k) clearance for remote scanning and remote protocol-adjustment capabilities within its Radiology Operations Command Center. This allows experienced personnel to support technologists across locations, which is strategically relevant for multi-hospital systems, rural sites, and outpatient networks facing staffing gaps. Remote operations are likely to become a standard feature in enterprise imaging contracts rather than a standalone pilot technology.

MRI innovation accelerated through lower-helium and AI-enabled platforms. In 2025, Siemens Healthineers received FDA clearance for the 1.5T MAGNETOM Flow.Ace, which uses a closed helium circuit containing approximately 0.7 liters of helium compared with more than 1,000 liters in many conventional systems. Philips continued to expand its BlueSeal and AI reconstruction capabilities, while deep-learning tools across the industry focused on faster scans, sharper images, and more consistent protocols. These developments directly address installation cost, sustainability, exam capacity, and workforce constraints.

CT competition intensified around spectral imaging, photon-counting, and AI reconstruction. Philips launched the CT 5300 in North America with AI-based reconstruction aimed at dose and image-quality improvement, while premium photon-counting systems continued to gain adoption in leading U.S. centers. The strategic question for manufacturers is how quickly these capabilities can move from tertiary institutions into community hospitals. Broader adoption will depend on workflow simplicity, clinical evidence, service support, and whether advanced imaging produces measurable downstream savings or diagnostic gains.

Breast imaging received a regulatory catalyst when updated federal mammography requirements became enforceable in September 2024, including standardized breast-density notification. The change is increasing patient and provider awareness of dense breast tissue and may support more risk-based supplemental imaging. The large U.S. mammography infrastructure—more than 8,800 certified facilities and over 12,000 accredited DBT units in 2024—creates a substantial upgrade market for tomosynthesis, AI-assisted detection, workflow software, biopsy systems, ultrasound, and breast MRI.

The FDA’s expanding list of AI-enabled medical devices also reinforces the central role of radiology in healthcare AI. Radiology represents the majority of authorized AI-enabled devices, reflecting the availability of digital image data and the potential to automate detection, segmentation, reconstruction, triage, and measurement. However, U.S. buyers are becoming more selective. Hospitals increasingly require evidence that an algorithm improves turnaround time, reduces missed findings, lowers repeat exams, or supports reimbursement. AI that creates additional alerts without improving workflow is unlikely to sustain premium adoption.

Conclusion

The U.S. Medical Imaging Systems Market Size & Share is positioned for sustained expansion from approximately USD 15.80 billion in 2025 to USD 30.50 billion by 2035, supported by a CAGR of 6.80% during the forecast period. The market’s long-term strength is grounded in aging demographics, high cancer and chronic-disease burden, large hospital and outpatient infrastructure, equipment replacement needs, and the central role of imaging across diagnostic and procedural care.

The most attractive growth opportunities will come from photon-counting and spectral CT, AI-accelerated MRI, low-helium magnets, molecular imaging and theranostics, digital breast tomosynthesis, remote scanning, point-of-care ultrasound, portable imaging, and enterprise fleet modernization. Mature categories such as fixed radiography, conventional CT, 1.5T MRI, and cart-based ultrasound will remain essential, but value growth will increasingly depend on technology that improves throughput, staffing efficiency, diagnostic confidence, and total cost of ownership.

Regional opportunity will be led by the South because of population scale, migration, hospital expansion, and aging demographics. The West will grow fastest through innovation adoption and outpatient expansion. The Northeast will remain the leading high-acuity and research market, while the Midwest will provide stable replacement demand and strong integrated-delivery-system opportunities. At the state level, Texas, Florida, California, New York, Pennsylvania, New Jersey, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, and Washington will remain especially important for manufacturers, service providers, distributors, and investors.

For clients evaluating this market, the central question is not whether U.S. imaging demand will grow. The more important questions are which modalities will capture premium capital, how quickly advanced technologies will move beyond academic centers, and which vendors can convert technical innovation into measurable clinical and operational value. Companies that combine reliable hardware, embedded AI, remote workflow, cybersecurity, lifecycle service, reimbursement understanding, and enterprise implementation capability will define the next decade of the U.S. medical imaging systems industry.

TABLE OF CONTENT

1. U.S. Medical Imaging Systems Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Medical Imaging Systems Included in the Study
1.2.2. Hardware, Embedded Software, Upgrades, and Service Revenue Coverage
1.2.3. Market Exclusions and Boundary Conditions
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up Installed-Base Assessment
1.3.6. Top-Down Healthcare Expenditure Assessment
1.3.7. Modality-Level Pricing and Shipment Analysis
1.3.8. Analytical Frameworks & Forecasting Models
1.3.9. Data Triangulation, Validation, and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Medical Imaging System Manufacturers
1.6.2. Detector, Magnet, Transducer, Tube, and Component Suppliers
1.6.3. Contract Manufacturers and Original Equipment Manufacturers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Independent Diagnostic Imaging Centers
1.6.6. Academic Medical Centers and Research Institutions
1.6.7. Specialty Clinics and Ambulatory Surgery Centers
1.6.8. Mobile Imaging and Rural Healthcare Providers
1.6.9. Group Purchasing Organizations and Distributors
1.6.10. Radiologists, Technologists, and Clinical Decision-Makers
1.6.11. Payers, Regulators, and Accreditation Organizations
1.6.12. Healthcare IT, PACS, Cloud, and Imaging AI Providers
**What this section provides:** This section defines the market boundary, study scope, methodology, assumptions, inclusions, exclusions, and stakeholder ecosystem used to measure and validate the U.S. medical imaging systems market.

2. U.S. Medical Imaging Systems Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size Forecast, 2021–2035 (US$ Billion)
2.8. Modality-Level Growth Comparison
2.9. Regional Growth Comparison
2.10. High-Growth Opportunity Areas
2.11. Key Investment Themes
2.12. Critical Success Factors for Market Participants
**What this section provides:** This section gives decision-makers a concise view of market size, historical development, forecast growth, modality performance, regional potential, competitive intensity, and priority investment opportunities.

3. U.S. Medical Imaging Systems Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Geriatric Population and Diagnostic Imaging Demand
3.1.2. Growing Cancer, Cardiovascular, Neurological, and Musculoskeletal Disease Burden
3.1.3. Replacement of Aging CT, MRI, X-ray, and Nuclear Imaging Systems
3.1.4. Expansion of Oncology Screening and Surveillance Programs
3.1.5. Growth of Outpatient and Independent Diagnostic Imaging Centers
3.1.6. Increasing Adoption of AI-Assisted Image Acquisition and Reconstruction
3.1.7. Hospital Demand for Faster Scanning and Higher Patient Throughput
3.1.8. Expansion of Image-Guided Procedures and Precision Medicine
3.1.9. Growth of Point-of-Care and Bedside Imaging
3.1.10. Imaging Technologist and Radiologist Workforce Constraints
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Installation Costs
3.2.2. Reimbursement Pressure and Declining Payment Per Examination
3.2.3. Long Hospital Capital Approval Cycles
3.2.4. MRI and Molecular Imaging Infrastructure Requirements
3.2.5. Shortage of Trained Imaging Technologists
3.2.6. Equipment Downtime and Service Contract Costs
3.2.7. Cybersecurity and Legacy System Integration Risks
3.2.8. Regulatory and Accreditation Compliance Burden
3.3. Opportunities and Their Impact Analysis
3.3.1. Photon-Counting and Spectral CT Adoption
3.3.2. Low-Helium and Helium-Sealed MRI Platforms
3.3.3. AI-Accelerated MRI and CT Reconstruction
3.3.4. Portable MRI and Mobile CT Deployment
3.3.5. Handheld and Point-of-Care Ultrasound Expansion
3.3.6. Digital Breast Tomosynthesis and Supplemental Breast Imaging
3.3.7. Molecular Imaging and Radiopharmaceutical Theranostics
3.3.8. Remote Scanning and Centralized Imaging Operations
3.3.9. Refurbished and Value-Tier Imaging Systems
3.3.10. Imaging Fleet Analytics and Predictive Maintenance
3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Economic Return on Premium Imaging Platforms
3.4.2. Managing Multi-Vendor Imaging Fleets
3.4.3. Achieving Interoperability Across PACS, RIS, EHR, and Cloud Systems
3.4.4. Scaling AI Without Increasing Workflow Burden
3.4.5. Balancing Diagnostic Quality, Dose, Speed, and Cost
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Installed-Base Replacement Cycle Analysis
3.7. Clinical Workflow Economics Analysis
3.8. Imaging Department Capacity and Utilization Analysis
3.9. Hospital Capital Procurement Behavior Analysis
3.10. Outpatient Imaging Economics Analysis
3.11. Imaging Workforce Availability and Productivity Analysis
**What this section provides:** This section explains the clinical, technological, reimbursement, workforce, capital-procurement, and operational forces shaping demand and helps clients evaluate market upside, adoption barriers, and execution risks.

4. U.S. Medical Imaging Systems Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Imaging System Pricing Trend Analysis, 2021–2035
4.3.1. CT System Pricing Trends
4.3.2. MRI System Pricing Trends
4.3.3. X-ray and Radiography System Pricing Trends
4.3.4. Ultrasound System Pricing Trends
4.3.5. Nuclear and Molecular Imaging System Pricing Trends
4.3.6. Refurbished Imaging System Pricing Trends
4.4. Pricing Trend Analysis by Region, 2025–2035
4.5. Value Chain & Supply Chain Analysis
4.5.1. Raw Materials and Specialized Components
4.5.2. Detectors, X-ray Tubes, Magnets, Coils, and Transducers
4.5.3. System Assembly and Software Integration
4.5.4. Distribution and Installation
4.5.5. Clinical Applications and Training
4.5.6. Maintenance, Upgrades, and Lifecycle Services
4.6. Imaging Equipment Supply Constraints and Lead-Time Analysis
4.7. Impact of Digitalization and Connected Imaging
4.8. Imaging AI and Software-Defined System Landscape
4.9. Application & Innovation Landscape
4.10. FDA Regulatory Framework Analysis
4.11. CMS Reimbursement and Coverage Landscape
4.12. Mammography Quality Standards Act Compliance Landscape
4.13. Imaging Accreditation and Quality Assurance Requirements
4.14. Radiation Dose Management and Patient Safety Framework
4.15. Import/Export Restrictions & Tariff Impact
4.16. Government Screening and Public Health Initiatives
4.17. Sustainability, Energy Efficiency, and Helium Conservation
4.18. Impact of Escalating Geopolitical Tensions
4.19. Imaging System Cybersecurity and Data Privacy Analysis
4.20. Hospital Value Analysis Committee Decision Framework
4.21. Total Cost of Ownership Assessment Framework
**What this section provides:** This section gives clients a complete view of regulation, reimbursement, accreditation, pricing, supply chain, digitalization, cybersecurity, sustainability, lifecycle economics, and hospital purchasing requirements.

5. U.S. Medical Imaging Systems Market – By Modality

5.1. Overview
5.1.1. Segment Share Analysis, By Modality, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
5.2. X-ray and Radiography Systems
5.2.1. Fixed Digital Radiography Systems
5.2.2. Mobile Digital Radiography Systems
5.2.3. Fluoroscopy Systems
5.2.4. Mobile and Fixed C-arm Systems
5.2.5. Mammography Systems
5.2.6. Digital Breast Tomosynthesis Systems
5.2.7. Dedicated and Specialty Radiography Systems
5.3. Computed Tomography Systems
5.3.1. Conventional Multi-Slice CT Systems
5.3.2. High-Slice and Cardiac CT Systems
5.3.3. Dual-Energy and Spectral CT Systems
5.3.4. Photon-Counting CT Systems
5.3.5. Portable and Mobile CT Systems
5.3.6. Intraoperative and Cone-Beam CT Systems
5.4. Magnetic Resonance Imaging Systems
5.4.1. 1.5-Tesla MRI Systems
5.4.2. 3-Tesla MRI Systems
5.4.3. Low-Field MRI Systems
5.4.4. Open and Wide-Bore MRI Systems
5.4.5. Ultra-High-Field MRI Systems
5.4.6. Portable and Bedside MRI Systems
5.4.7. Dedicated Extremity and Specialty MRI Systems
5.5. Ultrasound Systems
5.5.1. Premium Cart-Based Ultrasound Systems
5.5.2. Mid-Range and Compact Ultrasound Systems
5.5.3. Handheld Ultrasound Systems
5.5.4. Point-of-Care Ultrasound Systems
5.5.5. Cardiovascular Ultrasound Systems
5.5.6. Obstetric and Gynecological Ultrasound Systems
5.5.7. General, Vascular, and Specialty Ultrasound Systems
5.6. Nuclear and Molecular Imaging Systems
5.6.1. PET/CT Systems
5.6.2. SPECT/CT Systems
5.6.3. PET/MRI Systems
5.6.4. Dedicated Cardiac Nuclear Imaging Systems
5.6.5. Long-Axial-Field-of-View PET Systems
5.6.6. Organ-Specific Molecular Imaging Systems
**What this section provides:** This section identifies which imaging modalities and submodalities are expected to generate the largest revenue pools, fastest replacement demand, strongest premiumization, and highest growth through 2035.

6. U.S. Medical Imaging Systems Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
6.2. Oncology Imaging
6.2.1. Cancer Screening
6.2.2. Tumor Detection and Diagnosis
6.2.3. Cancer Staging
6.2.4. Treatment Planning
6.2.5. Therapy Response Monitoring
6.2.6. Recurrence and Survivorship Surveillance
6.3. Cardiology and Vascular Imaging
6.3.1. Coronary Artery Imaging
6.3.2. Structural Heart Imaging
6.3.3. Cardiac Function Assessment
6.3.4. Peripheral Vascular Imaging
6.3.5. Image-Guided Cardiovascular Procedures
6.4. Neurology Imaging
6.4.1. Stroke and Cerebrovascular Imaging
6.4.2. Brain Tumor Imaging
6.4.3. Dementia and Neurodegenerative Disease Imaging
6.4.4. Epilepsy and Functional Neuroimaging
6.4.5. Traumatic Brain and Spine Imaging
6.5. Orthopedic and Musculoskeletal Imaging
6.5.1. Sports Injury Imaging
6.5.2. Osteoarthritis and Degenerative Disease Imaging
6.5.3. Spine Imaging
6.5.4. Trauma and Fracture Assessment
6.5.5. Preoperative and Postoperative Orthopedic Imaging
6.6. Women’s Health Imaging
6.6.1. Breast Cancer Screening and Diagnosis
6.6.2. Dense-Breast Supplemental Imaging
6.6.3. Obstetric Imaging
6.6.4. Gynecological Imaging
6.6.5. Reproductive and Pelvic Imaging
6.7. Pulmonary and Thoracic Imaging
6.7.1. Lung Cancer Screening
6.7.2. Chronic Pulmonary Disease Imaging
6.7.3. Pulmonary Embolism Assessment
6.7.4. Infectious and Inflammatory Lung Imaging
6.8. Emergency, Trauma, and Critical-Care Imaging
6.8.1. Emergency Department Imaging
6.8.2. Trauma Center Imaging
6.8.3. Intensive-Care and Bedside Imaging
6.8.4. Intraoperative and Perioperative Imaging
6.9. Abdominal, Urological, and General Imaging
6.9.1. Abdominal and Gastrointestinal Imaging
6.9.2. Liver and Hepatobiliary Imaging
6.9.3. Renal and Urological Imaging
6.9.4. General Diagnostic Imaging
**What this section provides:** This section helps clients understand demand by clinical use case and prioritize applications with strong examination volumes, screening relevance, reimbursement support, procedural integration, and technology adoption.

7. U.S. Medical Imaging Systems Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
7.2. Hospitals and Integrated Health Systems
7.2.1. Large Academic and Tertiary Hospitals
7.2.2. Community Hospitals
7.2.3. Regional Hospital Networks
7.2.4. Critical-Access and Rural Hospitals
7.3. Independent Diagnostic Imaging Centers
7.3.1. Multi-Modality Imaging Centers
7.3.2. MRI and CT Centers
7.3.3. Women’s Imaging Centers
7.3.4. Mobile and Contract Imaging Providers
7.4. Specialty Clinics and Ambulatory Care Facilities
7.4.1. Orthopedic and Sports Medicine Clinics
7.4.2. Cardiology and Vascular Practices
7.4.3. Oncology and Cancer Centers
7.4.4. Women’s Health Practices
7.4.5. Ambulatory Surgery Centers
7.4.6. Urgent-Care and Emergency Centers
7.5. Academic Medical Centers and Research Institutions
7.5.1. University Hospitals
7.5.2. Clinical Research Organizations
7.5.3. Government and Veterans’ Healthcare Facilities
7.5.4. Advanced Imaging Research Centers
7.6. Home, Rural, Emergency, and Mobile Care Providers
7.6.1. Home Healthcare Providers
7.6.2. Rural Health Networks
7.6.3. Emergency Medical Services
7.6.4. Military and Field-Based Medical Services
**What this section provides:** This section explains which customer groups and care settings will drive capital investment, replacement cycles, outpatient adoption, research demand, and decentralized imaging deployment.

8. U.S. Medical Imaging Systems Market – By System Configuration

8.1. Overview
8.1.1. Segment Share Analysis, By System Configuration, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
8.2. Fixed Room-Based Imaging Systems
8.2.1. High-Capacity Hospital Imaging Systems
8.2.2. Outpatient Fixed Imaging Systems
8.2.3. Dedicated Specialty Imaging Rooms
8.3. Mobile and Cart-Based Imaging Systems
8.3.1. Mobile Radiography Systems
8.3.2. Mobile C-arms
8.3.3. Cart-Based Ultrasound Systems
8.3.4. Mobile CT Systems
8.4. Portable and Handheld Imaging Systems
8.4.1. Handheld Ultrasound Systems
8.4.2. Portable X-ray Systems
8.4.3. Portable and Bedside MRI Systems
8.4.4. Compact Point-of-Care Imaging Systems
8.5. Hybrid and Specialty Imaging Systems
8.5.1. PET/CT Systems
8.5.2. SPECT/CT Systems
8.5.3. PET/MRI Systems
8.5.4. Intraoperative Imaging Systems
8.5.5. Cone-Beam and Weight-Bearing CT Systems
8.5.6. Dedicated Breast and Organ-Specific Systems
8.6. AI-Enabled and Software-Defined Imaging Platforms
8.6.1. AI-Assisted Acquisition Systems
8.6.2. Deep-Learning Reconstruction Platforms
8.6.3. Automated Positioning and Protocol Selection
8.6.4. Remote Scanning and Command-Center Platforms
8.6.5. Imaging Fleet Analytics and Predictive Maintenance
**What this section provides:** This section evaluates how fixed, mobile, portable, hybrid, and software-defined imaging configurations are changing site-of-care economics, staffing requirements, infrastructure needs, and technology adoption.

9. U.S. Medical Imaging Systems Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
9.2. Direct Hospital and Health System Procurement
9.2.1. Individual Hospital Capital Purchases
9.2.2. Multi-Year Equipment Replacement Programs
9.2.3. Capital Lease and Managed Equipment Agreements
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Enterprise Vendor Standardization
9.3.2. Multi-Modality Fleet Contracts
9.3.3. Software and Service Bundling
9.3.4. Remote Operations and Fleet Management Agreements
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Contracts
9.4.2. Regional GPO Contracts
9.4.3. Aggregated Capital Procurement Programs
9.5. Distributor and Specialty Supplier Sales
9.5.1. Authorized Distributor Sales
9.5.2. Specialty Imaging Equipment Dealers
9.5.3. Refurbished and Pre-Owned Equipment Channels
9.6. Outpatient and Independent Imaging Procurement
9.6.1. Independent Imaging Center Purchases
9.6.2. Physician Practice Purchases
9.6.3. Ambulatory Surgery Center Purchases
9.6.4. Mobile Imaging Provider Purchases
9.7. Government, Veterans, and Public-Sector Procurement
9.7.1. Federal Government Procurement
9.7.2. Veterans Health Administration Procurement
9.7.3. State and Local Government Procurement
9.7.4. Military and Public Health Procurement
**What this section provides:** This section helps clients understand how medical imaging systems are purchased in the U.S., including direct capital procurement, IDN standardization, GPO influence, outpatient purchasing, financing, refurbished equipment, and public-sector contracting.

10. U.S. Medical Imaging Systems Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Installed-Base and Replacement Cycle Analysis
10.1.4. Regional Imaging Examination Volume Analysis
10.1.5. Regional Hospital and Outpatient Imaging Infrastructure Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Imaging Workforce Availability Analysis
10.1.8. Regional Technology Adoption and Capital Investment Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Medical Imaging System Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Medical Imaging System Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Medical Imaging System Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Medical Imaging System Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Modality, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By System Configuration, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
**What this section provides:** This section delivers detailed regional and state-level analysis, helping clients identify priority geographies, installed-base replacement opportunities, examination-volume hubs, advanced-technology adoption centers, outpatient growth markets, and state-level commercial opportunities.

11. U.S. Medical Imaging Systems Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Overall Market Share
11.1.2. Market Share by Modality
11.1.3. Market Share by End User
11.1.4. Market Share by Region
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Modality Portfolio Breadth
11.3.2. Installed Base and Service Coverage
11.3.3. Imaging AI and Software Capability
11.3.4. Clinical Application Strength
11.3.5. Enterprise Contracting Capability
11.3.6. Remote Operations and Fleet Management Capability
11.3.7. U.S. Regulatory and Innovation Pipeline
11.4. Company Profiles
11.4.1. GE HealthCare
11.4.2. Siemens Healthineers
11.4.3. Philips Healthcare
11.4.4. Canon Medical Systems USA
11.4.5. Fujifilm Healthcare Americas
11.4.6. United Imaging Healthcare
11.4.7. Hologic
11.4.8. Samsung Healthcare and NeuroLogica
11.4.9. Carestream Health
11.4.10. Konica Minolta Healthcare Americas
11.4.11. Shimadzu Medical Systems USA
11.4.12. Agfa HealthCare
11.4.13. Esaote North America
11.4.14. Mindray North America
11.4.15. Butterfly Network
11.4.16. Hyperfine
11.4.17. Clarius Mobile Health
11.4.18. Exo Imaging
11.4.19. Sectra
11.4.20. Planmed USA
11.4.21. Ziehm Imaging
11.4.22. Spectrum Dynamics Medical
11.4.23. Koning Corporation
11.4.24. CurveBeam AI
11.4.25. Nanox
**Note:** Each company profile will include company overview, imaging system portfolio, modality presence, U.S. market strategy, financial positioning, installed-base strategy, clinical pipeline, FDA updates, AI capabilities, partnerships, acquisitions, service infrastructure, and recent developments.
**What this section provides:** This section gives clients competitor benchmarking, market-share visibility, modality positioning, installed-base intelligence, innovation direction, service capability, and strategic analysis of leading and emerging medical imaging companies.

12. U.S. Medical Imaging Systems Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Photon-Counting CT
12.2.2. Spectral and Dual-Energy Imaging
12.2.3. AI-Accelerated MRI and CT Reconstruction
12.2.4. Low-Helium and Helium-Free MRI Platforms
12.2.5. Portable and Bedside MRI
12.2.6. Handheld and AI-Guided Ultrasound
12.2.7. Long-Axial-Field-of-View PET
12.2.8. Molecular Imaging and Theranostics
12.2.9. Remote Scanning and Imaging Command Centers
12.2.10. Autonomous Acquisition and Protocol Optimization
12.3. Emerging Business Trends
12.3.1. Imaging-as-a-Service Models
12.3.2. Managed Equipment Services
12.3.3. Multi-Vendor Fleet Management
12.3.4. Subscription-Based Software Upgrades
12.3.5. Outcome-Based Capital Contracting
12.3.6. Refurbished Equipment and Circular Economy Models
12.4. Business Opportunities for Startups and Existing Players
12.5. Modality Opportunity Assessment
12.6. State-Level Opportunity Assessment
12.7. Investment Prioritization Matrix
12.8. Technology Adoption Timeline, 2026–2035
12.9. Market Entry Risk Assessment
**What this section provides:** This section prepares clients for future technology shifts, evolving business models, market structure changes, investment opportunities, and imaging-system adoption scenarios through 2035.

13. U.S. Medical Imaging Systems Market: Strategic Recommendations

13.1. Recommendations for Medical Imaging System Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Independent Imaging Centers
13.4. Recommendations for Specialty Clinics and Ambulatory Providers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for Imaging AI and Software Companies
13.8. Recommendations for New Entrants and Startups
13.9. Go-to-Market Strategy Considerations
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Enterprise Contracting and Pricing Strategy
13.12. Clinical Evidence and Health-Economic Strategy
13.13. Regional and State-Level Commercial Prioritization
13.14. Partnership, Acquisition, and Licensing Strategy
13.15. Service, Training, and Customer-Retention Strategy
**What this section provides:** This section converts market intelligence into actionable recommendations for growth planning, portfolio development, market entry, pricing, contracting, channel expansion, investment decisions, and competitive differentiation.

14. U.S. Medical Imaging Systems Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Rounding Disclaimer
14.7. Company and Product Coverage Disclaimer
14.8. Regulatory and Reimbursement Change Disclaimer
**What this section provides:** This section clarifies the report’s scope limitations, legal boundaries, data-use terms, estimation methodology, rounding practices, third-party information treatment, and forecasting assumptions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Medical Imaging Systems Market: Market Definition and Scope
TABLE 3: U.S. Medical Imaging Systems Market: Research Methodology Framework
TABLE 4: U.S. Medical Imaging Systems Market: Key Assumptions
TABLE 5: U.S. Medical Imaging Systems Market: Market Ecosystem Overview
TABLE 6: U.S. Medical Imaging Systems Market: Stakeholder Analysis
TABLE 7: U.S. Medical Imaging Systems Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Medical Imaging Systems Market: Analyst Viewpoint Summary
TABLE 9: U.S. Medical Imaging Systems Market: Market Attractiveness Index
TABLE 10: U.S. Medical Imaging Systems Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Medical Imaging Systems Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Medical Imaging Systems Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Medical Imaging Systems Market: Drivers; Impact Analysis
TABLE 14: U.S. Medical Imaging Systems Market: Restraints; Impact Analysis
TABLE 15: U.S. Medical Imaging Systems Market: Opportunities; Impact Analysis
TABLE 16: U.S. Medical Imaging Systems Market: Challenges; Impact Analysis
TABLE 17: U.S. Medical Imaging Systems Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Medical Imaging Systems Market: Installed-Base Replacement Cycle Analysis
TABLE 19: U.S. Medical Imaging Systems Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Medical Imaging Systems Market: Imaging Department Capacity and Utilization Analysis
TABLE 21: U.S. Medical Imaging Systems Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Medical Imaging Systems Market: Outpatient Imaging Economics Analysis
TABLE 23: U.S. Medical Imaging Systems Market: Imaging Workforce Availability and Productivity Analysis
TABLE 24: U.S. Medical Imaging Systems Market: PESTEL Analysis
TABLE 25: U.S. Medical Imaging Systems Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Medical Imaging Systems Market: Imaging System Pricing Trend Analysis, 2021–2035
TABLE 27: U.S. Medical Imaging Systems Market: Pricing Trend Analysis by Modality, 2025–2035
TABLE 28: U.S. Medical Imaging Systems Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 29: U.S. Medical Imaging Systems Market: Value Chain Analysis
TABLE 30: U.S. Medical Imaging Systems Market: Supply Chain Analysis
TABLE 31: U.S. Medical Imaging Systems Market: Equipment Supply Constraints and Lead-Time Analysis
TABLE 32: U.S. Medical Imaging Systems Market: Digitalization and Connected Imaging Impact
TABLE 33: U.S. Medical Imaging Systems Market: Imaging AI and Software-Defined System Landscape
TABLE 34: U.S. Medical Imaging Systems Market: Application & Innovation Landscape
TABLE 35: U.S. Medical Imaging Systems Market: FDA Regulatory Framework Analysis
TABLE 36: U.S. Medical Imaging Systems Market: CMS Reimbursement and Coverage Landscape
TABLE 37: U.S. Medical Imaging Systems Market: Mammography Quality Standards Act Compliance Landscape
TABLE 38: U.S. Medical Imaging Systems Market: Imaging Accreditation and Quality Assurance Requirements
TABLE 39: U.S. Medical Imaging Systems Market: Radiation Dose Management and Patient Safety Framework
TABLE 40: U.S. Medical Imaging Systems Market: Import/Export Restrictions & Tariff Impact
TABLE 41: U.S. Medical Imaging Systems Market: Government Screening and Public Health Initiatives
TABLE 42: U.S. Medical Imaging Systems Market: Sustainability, Energy Efficiency, and Helium Conservation
TABLE 43: U.S. Medical Imaging Systems Market: Impact of Escalating Geopolitical Tensions
TABLE 44: U.S. Medical Imaging Systems Market: Imaging System Cybersecurity and Data Privacy Analysis
TABLE 45: U.S. Medical Imaging Systems Market: Hospital Value Analysis Committee Decision Framework
TABLE 46: U.S. Medical Imaging Systems Market: Total Cost of Ownership Assessment Framework
TABLE 47: U.S. Medical Imaging Systems Market: Modality Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Modality
TABLE 49: U.S. Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 50: U.S. Medical Imaging Systems Market: Segment Share Analysis, by Modality, 2025 & 2035 (%)
TABLE 51: U.S. Medical Imaging Systems Market: X-ray and Radiography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Medical Imaging Systems Market: Computed Tomography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Medical Imaging Systems Market: Magnetic Resonance Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Medical Imaging Systems Market: Ultrasound Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Medical Imaging Systems Market: Nuclear and Molecular Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Medical Imaging Systems Market: Application Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by Application
TABLE 58: U.S. Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 59: U.S. Medical Imaging Systems Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 60: U.S. Medical Imaging Systems Market: Oncology Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Medical Imaging Systems Market: Cardiology and Vascular Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Medical Imaging Systems Market: Neurology Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Medical Imaging Systems Market: Orthopedic and Musculoskeletal Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Medical Imaging Systems Market: Women’s Health Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Medical Imaging Systems Market: Pulmonary and Thoracic Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Medical Imaging Systems Market: Emergency, Trauma, and Critical-Care Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Medical Imaging Systems Market: Abdominal, Urological, and General Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Medical Imaging Systems Market: End User Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by End User
TABLE 70: U.S. Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 71: U.S. Medical Imaging Systems Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 72: U.S. Medical Imaging Systems Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Medical Imaging Systems Market: Independent Diagnostic Imaging Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Medical Imaging Systems Market: Specialty Clinics and Ambulatory Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Medical Imaging Systems Market: Academic Medical Centers and Research Institutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Medical Imaging Systems Market: Home, Rural, Emergency, and Mobile Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Medical Imaging Systems Market: System Configuration Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by System Configuration
TABLE 79: U.S. Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 80: U.S. Medical Imaging Systems Market: Segment Share Analysis, by System Configuration, 2025 & 2035 (%)
TABLE 81: U.S. Medical Imaging Systems Market: Fixed Room-Based Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Medical Imaging Systems Market: Mobile and Cart-Based Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Medical Imaging Systems Market: Portable and Handheld Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Medical Imaging Systems Market: Hybrid and Specialty Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Medical Imaging Systems Market: AI-Enabled and Software-Defined Imaging Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Medical Imaging Systems Market: Procurement Channel Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 88: U.S. Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 89: U.S. Medical Imaging Systems Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 90: U.S. Medical Imaging Systems Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: U.S. Medical Imaging Systems Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: U.S. Medical Imaging Systems Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: U.S. Medical Imaging Systems Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: U.S. Medical Imaging Systems Market: Outpatient and Independent Imaging Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: U.S. Medical Imaging Systems Market: Government, Veterans, and Public-Sector Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: U.S. Medical Imaging Systems Market: Regional Snapshot, 2025
TABLE 97: Segment Dashboard; Definition and Scope, by Region
TABLE 98: U.S. Medical Imaging Systems Market, by Region, 2021–2035 (US$ Billion)
TABLE 99: U.S. Medical Imaging Systems Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 100: West Region U.S. Medical Imaging Systems Market: Regional Overview and Trends
TABLE 101: West Region U.S. Medical Imaging Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 102: West Region U.S. Medical Imaging Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 105: West Region U.S. Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 106: West Region U.S. Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 107: West Region U.S. Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 108: California Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 109: California Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 110: California Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 111: California Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 112: California Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 113: Washington Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 114: Washington Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 115: Washington Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 116: Washington Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 117: Washington Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 118: Arizona Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 119: Arizona Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 120: Arizona Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 121: Arizona Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 122: Arizona Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 123: Colorado Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 124: Colorado Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 125: Colorado Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 126: Colorado Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 127: Colorado Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 128: Oregon Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 129: Oregon Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 130: Oregon Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 131: Oregon Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 132: Oregon Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 133: Utah Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 134: Utah Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 135: Utah Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 136: Utah Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 137: Utah Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Nevada Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 139: Nevada Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 140: Nevada Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 141: Nevada Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 142: Nevada Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 143: New Mexico Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 144: New Mexico Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 145: New Mexico Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 146: New Mexico Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 147: New Mexico Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: Idaho Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 149: Idaho Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 150: Idaho Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 151: Idaho Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 152: Idaho Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Montana Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 154: Montana Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 155: Montana Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 156: Montana Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 157: Montana Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Wyoming Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 159: Wyoming Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Wyoming Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Wyoming Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 162: Wyoming Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Alaska Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 164: Alaska Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: Alaska Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: Alaska Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 167: Alaska Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Hawaii Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 169: Hawaii Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Hawaii Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: Hawaii Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 172: Hawaii Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: Northeast Region U.S. Medical Imaging Systems Market: Regional Overview and Trends
TABLE 174: Northeast Region U.S. Medical Imaging Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 175: Northeast Region U.S. Medical Imaging Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 176: Northeast Region U.S. Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 177: Northeast Region U.S. Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 178: Northeast Region U.S. Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 179: Northeast Region U.S. Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 180: Northeast Region U.S. Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 181: New York Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 182: New York Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 183: New York Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 184: New York Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 185: New York Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 186: Massachusetts Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 187: Massachusetts Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 188: Massachusetts Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 189: Massachusetts Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 190: Massachusetts Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 191: New Jersey Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 192: New Jersey Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 193: New Jersey Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 194: New Jersey Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 195: New Jersey Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 196: Pennsylvania Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 197: Pennsylvania Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 198: Pennsylvania Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 199: Pennsylvania Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 200: Pennsylvania Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 201: Connecticut Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 202: Connecticut Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 203: Connecticut Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 204: Connecticut Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 205: Connecticut Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 206: Maine Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 207: Maine Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 208: Maine Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 209: Maine Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 210: Maine Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 211: Vermont Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 212: Vermont Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 213: Vermont Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 214: Vermont Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 215: Vermont Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 216: New Hampshire Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 217: New Hampshire Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: New Hampshire Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: New Hampshire Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 220: New Hampshire Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: Rhode Island Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 222: Rhode Island Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: Rhode Island Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 224: Rhode Island Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 225: Rhode Island Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Delaware Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 227: Delaware Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Delaware Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Delaware Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 230: Delaware Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: South Region U.S. Medical Imaging Systems Market: Regional Overview and Trends
TABLE 232: South Region U.S. Medical Imaging Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 233: South Region U.S. Medical Imaging Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 234: South Region U.S. Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 235: South Region U.S. Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 236: South Region U.S. Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 237: South Region U.S. Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 238: South Region U.S. Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 239: Texas Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 240: Texas Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 241: Texas Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 242: Texas Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 243: Texas Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 244: Florida Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 245: Florida Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 246: Florida Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 247: Florida Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 248: Florida Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 249: Georgia Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 250: Georgia Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 251: Georgia Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 252: Georgia Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 253: Georgia Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 254: North Carolina Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 255: North Carolina Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 256: North Carolina Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 257: North Carolina Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 258: North Carolina Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 259: Tennessee Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 260: Tennessee Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 261: Tennessee Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 262: Tennessee Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 263: Tennessee Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 264: South Carolina Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 265: South Carolina Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 266: South Carolina Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 267: South Carolina Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 268: South Carolina Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 269: Alabama Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 270: Alabama Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 271: Alabama Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 272: Alabama Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 273: Alabama Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 274: Mississippi Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 275: Mississippi Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 276: Mississippi Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 277: Mississippi Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 278: Mississippi Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 279: Louisiana Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 280: Louisiana Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 281: Louisiana Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 282: Louisiana Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 283: Louisiana Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 284: Arkansas Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 285: Arkansas Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 286: Arkansas Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 287: Arkansas Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 288: Arkansas Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 289: Kentucky Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 290: Kentucky Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 291: Kentucky Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 292: Kentucky Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 293: Kentucky Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 294: Oklahoma Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 295: Oklahoma Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 296: Oklahoma Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 297: Oklahoma Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 298: Oklahoma Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 299: Virginia Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 300: Virginia Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: Virginia Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 302: Virginia Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 303: Virginia Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Maryland Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 305: Maryland Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Maryland Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Maryland Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 308: Maryland Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: West Virginia Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 310: West Virginia Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: West Virginia Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: West Virginia Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 313: West Virginia Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Midwest Region U.S. Medical Imaging Systems Market: Regional Overview and Trends
TABLE 315: Midwest Region U.S. Medical Imaging Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 316: Midwest Region U.S. Medical Imaging Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 317: Midwest Region U.S. Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 318: Midwest Region U.S. Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 319: Midwest Region U.S. Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 320: Midwest Region U.S. Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 321: Midwest Region U.S. Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 322: Illinois Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 323: Illinois Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 324: Illinois Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 325: Illinois Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 326: Illinois Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 327: Ohio Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 328: Ohio Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 329: Ohio Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 330: Ohio Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 331: Ohio Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 332: Michigan Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 333: Michigan Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 334: Michigan Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 335: Michigan Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 336: Michigan Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 337: Minnesota Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 338: Minnesota Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 339: Minnesota Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 340: Minnesota Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 341: Minnesota Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 342: Indiana Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 343: Indiana Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 344: Indiana Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 345: Indiana Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 346: Indiana Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 347: Wisconsin Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 348: Wisconsin Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 349: Wisconsin Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 350: Wisconsin Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 351: Wisconsin Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 352: Missouri Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 353: Missouri Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 354: Missouri Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 355: Missouri Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 356: Missouri Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 357: Iowa Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 358: Iowa Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 359: Iowa Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 360: Iowa Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 361: Iowa Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 362: Kansas Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 363: Kansas Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 364: Kansas Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 365: Kansas Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 366: Kansas Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 367: Nebraska Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 368: Nebraska Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 369: Nebraska Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 370: Nebraska Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 371: Nebraska Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 372: North Dakota Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 373: North Dakota Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 374: North Dakota Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 375: North Dakota Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 376: North Dakota Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 377: South Dakota Medical Imaging Systems Market, by Modality, 2021–2035 (US$ Billion)
TABLE 378: South Dakota Medical Imaging Systems Market, by Application, 2021–2035 (US$ Billion)
TABLE 379: South Dakota Medical Imaging Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 380: South Dakota Medical Imaging Systems Market, by System Configuration, 2021–2035 (US$ Billion)
TABLE 381: South Dakota Medical Imaging Systems Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 382: U.S. Medical Imaging Systems Market: Competitive Landscape Snapshot, 2025
TABLE 383: U.S. Medical Imaging Systems Market: Key Company Market Share Analysis, 2025
TABLE 384: U.S. Medical Imaging Systems Market: Market Share Analysis by Modality, 2025
TABLE 385: U.S. Medical Imaging Systems Market: Market Share Analysis by End User, 2025
TABLE 386: U.S. Medical Imaging Systems Market: Market Share Analysis by Region, 2025
TABLE 387: U.S. Medical Imaging Systems Market: Company Positioning Matrix
TABLE 388: U.S. Medical Imaging Systems Market: Modality Portfolio Breadth Benchmarking
TABLE 389: U.S. Medical Imaging Systems Market: Installed Base and Service Coverage Benchmarking
TABLE 390: U.S. Medical Imaging Systems Market: Imaging AI and Software Capability Benchmarking
TABLE 391: U.S. Medical Imaging Systems Market: Clinical Application Strength Benchmarking
TABLE 392: U.S. Medical Imaging Systems Market: Enterprise Contracting Capability Benchmarking
TABLE 393: U.S. Medical Imaging Systems Market: Remote Operations and Fleet Management Benchmarking
TABLE 394: U.S. Medical Imaging Systems Market: U.S. Regulatory and Innovation Pipeline Benchmarking
TABLE 395: U.S. Medical Imaging Systems Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 396: GE HealthCare: Company Profile
TABLE 397: Siemens Healthineers: Company Profile
TABLE 398: Philips Healthcare: Company Profile
TABLE 399: Canon Medical Systems USA: Company Profile
TABLE 400: Fujifilm Healthcare Americas: Company Profile
TABLE 401: United Imaging Healthcare: Company Profile
TABLE 402: Hologic: Company Profile
TABLE 403: Samsung Healthcare and NeuroLogica: Company Profile
TABLE 404: Carestream Health: Company Profile
TABLE 405: Konica Minolta Healthcare Americas: Company Profile
TABLE 406: Shimadzu Medical Systems USA: Company Profile
TABLE 407: Agfa HealthCare: Company Profile
TABLE 408: Esaote North America: Company Profile
TABLE 409: Mindray North America: Company Profile
TABLE 410: Butterfly Network: Company Profile
TABLE 411: Hyperfine: Company Profile
TABLE 412: Clarius Mobile Health: Company Profile
TABLE 413: Exo Imaging: Company Profile
TABLE 414: Sectra: Company Profile
TABLE 415: Planmed USA: Company Profile
TABLE 416: Ziehm Imaging: Company Profile
TABLE 417: Spectrum Dynamics Medical: Company Profile
TABLE 418: Koning Corporation: Company Profile
TABLE 419: CurveBeam AI: Company Profile
TABLE 420: Nanox: Company Profile
TABLE 421: U.S. Medical Imaging Systems Market: Future Market Scenario Analysis, 2026–2035
TABLE 422: U.S. Medical Imaging Systems Market: Disruptive Technologies Impact Matrix
TABLE 423: U.S. Medical Imaging Systems Market: Emerging Business Trends
TABLE 424: U.S. Medical Imaging Systems Market: Business Opportunities for Startups and Existing Players
TABLE 425: U.S. Medical Imaging Systems Market: Modality Opportunity Assessment
TABLE 426: U.S. Medical Imaging Systems Market: State-Level Opportunity Assessment
TABLE 427: U.S. Medical Imaging Systems Market: Investment Prioritization Matrix
TABLE 428: U.S. Medical Imaging Systems Market: Technology Adoption Timeline, 2026–2035
TABLE 429: U.S. Medical Imaging Systems Market: Market Entry Risk Assessment
TABLE 430: U.S. Medical Imaging Systems Market: Strategic Recommendations for Medical Imaging System Manufacturers
TABLE 431: U.S. Medical Imaging Systems Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 432: U.S. Medical Imaging Systems Market: Strategic Recommendations for Independent Imaging Centers
TABLE 433: U.S. Medical Imaging Systems Market: Strategic Recommendations for Specialty Clinics and Ambulatory Providers
TABLE 434: U.S. Medical Imaging Systems Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 435: U.S. Medical Imaging Systems Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 436: U.S. Medical Imaging Systems Market: Strategic Recommendations for Imaging AI and Software Companies
TABLE 437: U.S. Medical Imaging Systems Market: Strategic Recommendations for New Entrants and Startups
TABLE 438: U.S. Medical Imaging Systems Market: Go-to-Market Strategy Considerations
TABLE 439: U.S. Medical Imaging Systems Market: Product Positioning and Portfolio Expansion Guidance
TABLE 440: U.S. Medical Imaging Systems Market: Enterprise Contracting and Pricing Strategy
TABLE 441: U.S. Medical Imaging Systems Market: Clinical Evidence and Health-Economic Strategy
TABLE 442: U.S. Medical Imaging Systems Market: Regional and State-Level Commercial Prioritization
TABLE 443: U.S. Medical Imaging Systems Market: Partnership, Acquisition, and Licensing Strategy
TABLE 444: U.S. Medical Imaging Systems Market: Service, Training, and Customer-Retention Strategy
TABLE 445: U.S. Medical Imaging Systems Market: Scope Limitation
TABLE 446: U.S. Medical Imaging Systems Market: Data Use Limitation
TABLE 447: U.S. Medical Imaging Systems Market: Forecasting Limitation
TABLE 448: U.S. Medical Imaging Systems Market: Legal Disclaimer
TABLE 449: U.S. Medical Imaging Systems Market: Third-Party Data Disclaimer
TABLE 450: U.S. Medical Imaging Systems Market: Market Estimation and Rounding Disclaimer
TABLE 451: U.S. Medical Imaging Systems Market: Company and Product Coverage Disclaimer
TABLE 452: U.S. Medical Imaging Systems Market: Regulatory and Reimbursement Change Disclaimer

List of Figures

FIGURE 1: U.S. Medical Imaging Systems Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem Overview
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Installed-Base Replacement Cycle Framework
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Imaging Department Capacity and Utilization Framework
FIGURE 14: Hospital Capital Procurement Decision Framework
FIGURE 15: Outpatient Imaging Economics Framework
FIGURE 16: Imaging Workforce Availability and Productivity Framework
FIGURE 17: U.S. Medical Imaging Systems Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 18: U.S. Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 19: U.S. Medical Imaging Systems Market Year-wise Growth Curve, 2021–2035
FIGURE 20: Modality Segment Market Share Analysis, 2025 & 2035
FIGURE 21: Modality Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: X-ray and Radiography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Computed Tomography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Magnetic Resonance Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Ultrasound Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Nuclear and Molecular Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 28: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Oncology Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Cardiology and Vascular Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Neurology Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Orthopedic and Musculoskeletal Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Women’s Health Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Pulmonary and Thoracic Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Emergency, Trauma, and Critical-Care Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Abdominal, Urological, and General Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 38: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Independent Diagnostic Imaging Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Specialty Clinics and Ambulatory Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Academic Medical Centers and Research Institutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Home, Rural, Emergency, and Mobile Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: System Configuration Segment Market Share Analysis, 2025 & 2035
FIGURE 45: System Configuration Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Fixed Room-Based Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Mobile and Cart-Based Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Portable and Handheld Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Hybrid and Specialty Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: AI-Enabled and Software-Defined Imaging Platforms Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 52: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Outpatient and Independent Imaging Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Government, Veterans, and Public-Sector Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 60: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: West Region U.S. Medical Imaging Systems Market Share and Leading Players, 2025
FIGURE 62: West Region Market Share Analysis by State, 2025
FIGURE 63: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: California Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Washington Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Arizona Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Colorado Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Oregon Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Utah Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Nevada Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New Mexico Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Idaho Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Montana Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Wyoming Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Alaska Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Hawaii Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Northeast Region U.S. Medical Imaging Systems Market Share and Leading Players, 2025
FIGURE 78: Northeast Region Market Share Analysis by State, 2025
FIGURE 79: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New York Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Massachusetts Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Jersey Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Pennsylvania Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Connecticut Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Maine Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Vermont Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: New Hampshire Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Rhode Island Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Delaware Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: South Region U.S. Medical Imaging Systems Market Share and Leading Players, 2025
FIGURE 91: South Region Market Share Analysis by State, 2025
FIGURE 92: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Texas Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Florida Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Georgia Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: North Carolina Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Tennessee Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: South Carolina Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Alabama Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Mississippi Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Louisiana Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Arkansas Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Kentucky Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Oklahoma Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Virginia Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Maryland Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: West Virginia Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Midwest Region U.S. Medical Imaging Systems Market Share and Leading Players, 2025
FIGURE 109: Midwest Region Market Share Analysis by State, 2025
FIGURE 110: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Illinois Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Ohio Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Michigan Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Minnesota Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Indiana Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Wisconsin Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Missouri Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Iowa Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Kansas Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Nebraska Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: North Dakota Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: South Dakota Medical Imaging Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 124: Company Positioning Matrix
FIGURE 125: Key Player Modality Portfolio Benchmarking
FIGURE 126: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 127: Medical Imaging Systems Innovation Roadmap
FIGURE 128: Photon-Counting and Spectral CT Adoption Roadmap
FIGURE 129: Low-Helium and AI-Accelerated MRI Opportunity Roadmap
FIGURE 130: Portable Imaging and Point-of-Care Ultrasound Growth Roadmap
FIGURE 131: Molecular Imaging and Theranostics Opportunity Map
FIGURE 132: Remote Scanning and Imaging Command Center Adoption Roadmap
FIGURE 133: Future Market Scenario Analysis, 2026–2035
FIGURE 134: Disruptive Technologies Impact Matrix
FIGURE 135: Emerging Business Trends Matrix
FIGURE 136: Investment Prioritization Matrix
FIGURE 137: Strategic Growth Roadmap for U.S. Medical Imaging System Companies
FIGURE 138: Go-to-Market Strategy Framework
FIGURE 139: Product Positioning and Portfolio Expansion Framework
FIGURE 140: Report Scope and Disclaimer Framework